Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
11/2010
11/11/2010US20100286199 Novel fungicides
11/11/2010US20100286109 Amide derivatives as positive allosteric modulators and methods of use thereof
11/11/2010CA2761009A1 Compounds and methods for inhibition of renin, and indications therefor
11/10/2010EP2248804A1 Combined use of angiogenesis inhibitor and taxane
11/10/2010CN101880273A Benzo-hexahydric N-heterocyclic derivatives, preparation method and application thereof in medicines
11/09/2010US7829717 such as 3-[(Quinolin-4-ylmethyl)amino]-N-[4-methyl-3-(2-(4-(2-propyl)piperazin-1-yl)-3,4-dioxocyclobut-1-en-1-yl)phenyl]thiophene-2-carboxamide, having stem cell factor receptor inhibitory activity, used antitumor or anticarcinogenic agents
11/09/2010US7829716 decyclization of {3-[(E)-2(7-chloro-2-quinolinyl)vinyl]phenyl}-4,5-dihydro-3H-benzo[c]thiepin-1-one by methylmagnesium halide with following conversion to montelukast
11/09/2010US7829578 Aromatic ketones and uses thereof
11/09/2010US7829564 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/04/2010WO2010077062A3 Preparation method of statin compound and benzothiazolyl sulfone compound used therein
11/04/2010WO2010073078A3 Heterocyclic compounds as hdac inhibitors
11/04/2010WO2009087684A3 Novel tetrahydroquinolines as aromatase inhibitors
11/04/2010US20100280248 Novel compounds that are useful for improving pharmacokinetics
11/04/2010US20100280070 Novel tetrahydroquinolines as aromatase inhibitors
11/04/2010US20100280068 Quinoline derivatives and their use as fungicides
11/04/2010US20100280034 Modulation of pathogenicity
11/04/2010US20100280024 Renin inhibitors
11/04/2010US20100279340 Imaging agents for protein misfolding
11/03/2010EP2118063B1 A method for the preparation of montelukast
11/03/2010EP1954274B1 Substituted quinolones and methods of use
11/03/2010EP1496838B1 Substituted amides
11/03/2010EP1487795B1 Synthesis of enantiomerically pure amino-substituted fused bicyclic rings
11/03/2010CN101878027A Receptor targeting ligands
11/02/2010US7825264 Substituted heterocycles, their use as medicament, and pharmaceutical preparations comprising them
11/02/2010US7825254 Heteroaromatic quinoline compounds
11/02/2010US7825253 2-aminoquinoline derivatives
11/02/2010US7825252 Intermediates to 4-oxoquinolone compounds such as 6-(3-chloro-2-fluorobenzyl)-1-[(S)-1-hydroxymethyl-2-methylpropyl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid that are HIV integrase inhibitors; eliminate the use of toxic or costly reagents
11/02/2010US7825251 preparing 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone (cilostazol) by reacting 6-hydroxy-3,4-dihydroquinoline-2(1H)-one and 5-(4-chlorobutyl)-1-cyclohexyl-1H-tetrazole in an aqueous single phase
11/02/2010US7825244 4-(7-chloro-quinazolin-4-yl)-piperidine; use in the synthesis of protein tyrosine kinase inhibitors, particularly inhibitors of FLT3 and/or c-kit and/or TrkB
11/02/2010US7825131 Quinoline potassium channel inhibitors
11/02/2010CA2389681C Npy y5 antagonist
10/2010
10/28/2010WO2010123337A1 Enrofloxacin complex with maximum residence time in the plasma of mammals and birds
10/28/2010WO2010123139A1 Arylcarboxamide derivative having sulfamoyl group
10/28/2010WO2010122968A1 Diacylethylenediamine compound
10/28/2010WO2010089770A3 Processes for preparing pitavas tatin, intermediates and pharmaceutically acceptable salts thereof
10/28/2010US20100274051 Inflammatory cytokine release inhibitor
10/28/2010US20100273824 Substituted 1,3-dioxanes and their uses
10/28/2010US20100273819 3,3'-Spiroindolinone Derivatives
10/28/2010CA2759264A1 Diacylethylenediamine compound
10/27/2010EP2099761B1 Antibacterial quinoline derivatives
10/27/2010EP1386914B1 Halogenated quinoline derivatives and ectoparasite controllers
10/27/2010CN101870696A N-aryl piperazine derivative having double activity of dopamine D2 and 5-HT2a
10/27/2010CN101870674A Improved preparation method of rebamipide intermediate
10/26/2010US7820824 As labeling reagents for a variety of biological applications
10/26/2010US7820823 Dual action antibiotics
10/26/2010US7820694 Administering an aminoindanyl derivative and; a steroid, dopamine receptor agonist or an anticholinergic or antimuscarinic agent; respiratory system disorders, antiallergens, chronic obstructive pulmonary disease, adult respiratory distress syndrome, bronchitis
10/26/2010US7820675 Benzofuran compounds
10/26/2010US7820664 N-(2-aylamino)aryl sulfonamides such as N-(7-(4-bromo-2-fluorophenylamino)imidazo[1,2-b]pyridazin-6-yl)-1-(2-hydroxyethyl)cyclopropane-1-sulfonamide; mitogen-activated ERK activating kinase (MEK) inhibitors; antiproliferative, anticarcinogenic, and antiinflammatory agents
10/26/2010CA2543650C A crystalline form of the salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide or the solvate of the salt and a process for preparing thesame
10/26/2010CA2449192C Novel nitriles useful as reversible inhibitors of cysteine proteases
10/26/2010CA2192928C Benzoheterocyclic derivatives
10/21/2010WO2010118661A1 Method for preparation metal compounds of 8-hydroxyquinoline or derivatives
10/21/2010US20100267958 Method for isolation and purification of montelukast
10/21/2010US20100267956 Chiral tridentate compounds, corresponding organometal complexes, method for preparing same and use of said compounds and complexes as ligands in asymmetrical catalysis
10/21/2010US20100267768 Process for making modulators of cystic fibrosis transmembrane conductance regulator
10/21/2010US20100267754 Integrin expression inhibitor
10/21/2010US20100267712 Isoindoline compounds for the treatment of spinal muscular atrophy and other uses
10/21/2010US20100267711 Method of enhancing cellular production of molecular chaperone, hydroxylamine derivatives useful for enhancing the chaperone production and the preparation thereof
10/21/2010US20100267697 Ion channel modulators
10/21/2010US20100267609 Compounds which inhibit beta-secretase activity and methods of use thereof
10/21/2010US20100266621 Methods and systems for treating cell proliferation disorders with psoralen derivatives
10/20/2010EP2241564A1 3,8-diaminotetrahydroquinoline derivative
10/20/2010EP2240450A1 Trpa1 antagonists
10/20/2010EP2240016A1 Ampk modulators
10/20/2010EP1899299B1 C-linked cyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
10/20/2010EP1539698B1 Method for producing a 3,5-dihydroxy-6-heptenoate
10/20/2010CN101868448A 5-[(3,3,3-trifluoro-2-hydroxy-1-arylpropyl)amino]-1h-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents
10/20/2010CN101868447A Method of making and administering quinoline derivatives as anti-cancer agents
10/20/2010CN101863831A Method for separating quinoline from coal and biomass coliquified oil product
10/20/2010CN101863825A Ionic liquid containing carbamido group and pyridinium main ring and preparation method thereof
10/20/2010CN101863823A 2-oxindole compounds, and ring-enlargement derivatives, preparation method and application thereof
10/20/2010CN101863780A Choline salt of hypolipidemic drug and preparation method and pharmaceutical use thereof
10/20/2010CN101302194B Synthetic method of polysubstituted chinoline compound
10/19/2010US7816534 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
10/19/2010US7816408 (N-{5-[(4-chlorophenyl)thio]pentyl}-N-[(1R)-1-(1-naphthyl)ethyl]amine); mimics/blocks effect of extracellular calcium in parathyroid cells, juxtaglomerular/proximal tubule kidney cells, parafollicular thyroid cells, bone osteoclasts, keratinocytes or placental trophoblasts; hyperparathyroidism
10/19/2010US7816397 Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes
10/19/2010US7816372 (R)-6-(2-(2,2,2-Trifluoroethyl)-1-pyrrolidinyl)-4-trifluoromethyl-2(1H)-quinolinone; partial agonist, agonist or antagonist of androgen receptor; cachexia and wasting diseases; male-pattern baldness; benign prostatic hyperplasia; hirsutism; acne
10/19/2010US7816352 Apoptosis inhibitors
10/19/2010CA2443484C Halogen-substituted quinoline derivatives and ectoparasite control agent
10/19/2010CA2429496C Substituted carbostyril derivatives as 5-ht1a receptor subtype agonists
10/19/2010CA2427282C Mixtures or organic compounds for the treatment of airway diseases
10/14/2010WO2010116270A1 Ep2/4 agonists
10/14/2010WO2010116122A2 Herbicidal compounds
10/14/2010WO2010065905A3 Compounds having antiparasitic or anti-infectious activity
10/14/2010WO2007004237A3 A process for the preparation of montelukast
10/14/2010US20100261900 Process for the palladium-catalyzed coupling of terminal alkynes with heteroaryl tosylates and heteroaryl benzenesulfonates
10/14/2010US20100261758 Heterocyclic amides for use as pharmaceuticals
10/14/2010US20100261751 Method for determining one of the two human immunodeficiency virus (hiv) integrase enzymatic activities
10/14/2010US20100261679 CSF-1R, Inhibitors, Compositions, and Methods of Use
10/14/2010US20100261675 Fungicidal composition containing acid amide derivative
10/14/2010CA2758072A1 Macrocyclic serine protease inhibitors
10/14/2010CA2757665A1 Herbicidal compounds
10/13/2010EP2239260A1 Novel compounds with antibacterial activity
10/13/2010EP2238111A1 6-substituted-thio-2-amino-quinoline derivatives useful as inhibitors of -secretase (bace)
10/13/2010CN101861305A Chiral tridentate compounds, corresponding organometal complexes, method for preparing same and use of said compounds and complexes as ligands in asymmetrical catalysis
10/13/2010CN101857602A Preparation method for Prulifloxacin
10/13/2010CN101857568A Preparation method of 8-hydroxyquinoline zinc with shape of octahedron
10/13/2010CN101039671B Non-peptide bradykinin antagonists and pharmaceutical compositions therefrom
10/12/2010US7812168 Purification of montelukast
10/12/2010US7812038 such as vascular cell adhesion molecules and fibronectins, administered for the treatment of asthma, multiple sclerosis or inflammatory bowel diseases in mammals; (3S)-3-{[({1-[(2-chlorophenyl)methyl]-4-hydroxy-2-oxo-1,2-dihydro-3quinolinyl}amino)carbonyl]amino}-3-(4-methylphenyl)propanoic acid
1 ... 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 ... 277